Novo Nordisk Falls, State Street Drops, Zions Plunges on Losses From Alleged Fraud On this episode of Stock Movers:
On this episode of Stock Movers:- Novo Nordisk (NOVO) shares fall after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Talks over the price of weight-loss drugs, including Ozempic, are still ongoing, according to Mehmet Oz, head of the Centers for Medicare and Medicaid Services.- State Street (STT) shares drop after the financial manager’s net interest income fell short of expectations in the third quarter. The company’s adjusted earnings per share for the quarter that beat the average analyst estimate.- Zion (ZION) shares…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.